Carvedilol: An anti-inflammatory and anti-atherogenic β-blocker?

Acta Cardiologica Sinica

Volumn 19, Issue 2, 2003, Pages 93-94

  Chen, Jin Jer ^a   Shih, Neng Lang ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; INTERLEUKIN 10;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BETA ADRENERGIC RECEPTOR BLOCKING; CYTOKINE PRODUCTION; DRUG MECHANISM; NOTE; TH2 CELL;

EID: 0043023793     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Lalani I, Bhol K, Razzaque Ahmed A. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997;79:469-4.
2. Spencer SD, Di Marco F, Hooley J, et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998;187:571-8.
3. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin-10 signaling blocks inhibitor of 6B kinase activity and nuclear factor 6B DNA binding. J Biol Chem 1999;274:31868-74.
4. Downing LJ, Strieter RM, Kadell AM, et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 1998;161:1471-6.
5. Morise Z, Eppihimer M, Granger DN, et al. Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 1993;23:99-110.
6. Henke PK, DeBrunye LA, Strieter RM, et al. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J Immunol 2000;164:2131-41.
7. Takeshita S, Gage JR, Kishimoto T, et al. Differential regulation of IL-5 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996;156:2591-8.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
9. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999;99:348-53.
10. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
11. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001;88:877-87.
12. Mallat Z, Heymes C, Ohan J, et al. Expression of interleukin-10 in human atherosclerotic plaque. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999;19:611-6.
13. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atheroclerosis. Circ Res 1999;85(supple):17-24.
14. Pinderski Oslund LJ, Hedrick CC, Olvera T, et al. Interleukin-10 blocks atherosclerotic events in vitro. Arterioscler Thromb Vasc Biol 1999;19:2847-53.
15. Cheng SM, Yang SP, Tsao DP. Et al. Carvedilol Modulates In Vitro Lipopolysacchalride-induced Interleukin-10 Production in Monocytic Cells. Acta Cardiol Sin 2003;19:79-88.